Cargando…
Comparison of the applicability of Hasford score and European Treatment and Outcome Study score in Indian patients with chronic phase chronic myeloid leukemia on imatinib therapy
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615880/ https://www.ncbi.nlm.nih.gov/pubmed/28975119 http://dx.doi.org/10.4103/sajc.sajc_57_17 |
| _version_ | 1783266682278510592 |
|---|---|
| author | Narang, Neha Chopra Kotru, Mrinalini Sikka, Meera Rusia, Usha |
| author_facet | Narang, Neha Chopra Kotru, Mrinalini Sikka, Meera Rusia, Usha |
| author_sort | Narang, Neha Chopra |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5615880 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-56158802017-10-03 Comparison of the applicability of Hasford score and European Treatment and Outcome Study score in Indian patients with chronic phase chronic myeloid leukemia on imatinib therapy Narang, Neha Chopra Kotru, Mrinalini Sikka, Meera Rusia, Usha South Asian J Cancer Letter to the Editor Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5615880/ /pubmed/28975119 http://dx.doi.org/10.4103/sajc.sajc_57_17 Text en Copyright: © 2017 The South Asian Journal of Cancer http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
| spellingShingle | Letter to the Editor Narang, Neha Chopra Kotru, Mrinalini Sikka, Meera Rusia, Usha Comparison of the applicability of Hasford score and European Treatment and Outcome Study score in Indian patients with chronic phase chronic myeloid leukemia on imatinib therapy |
| title | Comparison of the applicability of Hasford score and European Treatment and Outcome Study score in Indian patients with chronic phase chronic myeloid leukemia on imatinib therapy |
| title_full | Comparison of the applicability of Hasford score and European Treatment and Outcome Study score in Indian patients with chronic phase chronic myeloid leukemia on imatinib therapy |
| title_fullStr | Comparison of the applicability of Hasford score and European Treatment and Outcome Study score in Indian patients with chronic phase chronic myeloid leukemia on imatinib therapy |
| title_full_unstemmed | Comparison of the applicability of Hasford score and European Treatment and Outcome Study score in Indian patients with chronic phase chronic myeloid leukemia on imatinib therapy |
| title_short | Comparison of the applicability of Hasford score and European Treatment and Outcome Study score in Indian patients with chronic phase chronic myeloid leukemia on imatinib therapy |
| title_sort | comparison of the applicability of hasford score and european treatment and outcome study score in indian patients with chronic phase chronic myeloid leukemia on imatinib therapy |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615880/ https://www.ncbi.nlm.nih.gov/pubmed/28975119 http://dx.doi.org/10.4103/sajc.sajc_57_17 |
| work_keys_str_mv | AT narangnehachopra comparisonoftheapplicabilityofhasfordscoreandeuropeantreatmentandoutcomestudyscoreinindianpatientswithchronicphasechronicmyeloidleukemiaonimatinibtherapy AT kotrumrinalini comparisonoftheapplicabilityofhasfordscoreandeuropeantreatmentandoutcomestudyscoreinindianpatientswithchronicphasechronicmyeloidleukemiaonimatinibtherapy AT sikkameera comparisonoftheapplicabilityofhasfordscoreandeuropeantreatmentandoutcomestudyscoreinindianpatientswithchronicphasechronicmyeloidleukemiaonimatinibtherapy AT rusiausha comparisonoftheapplicabilityofhasfordscoreandeuropeantreatmentandoutcomestudyscoreinindianpatientswithchronicphasechronicmyeloidleukemiaonimatinibtherapy |